Paper17522949
The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.
Miesbach W and 7 others. Clin Rheumatol, 2007. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome. Papers, record 17522949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17522949
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The role of malignancies in patients with catastrophic anti-phospholipid (Asherson's) syndrome.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiphospholipid Syndrome | Major topic |
| Neoplasms | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Anticoagulants | |
| Child | |
| Female | |
| Glucocorticoids | |
| Humans | |
| Immunosuppressive Agents | |
| Incidence | |
| Male | |
| Middle Aged | |
| Plasma Exchange | |
| Prognosis | |
| Renal Dialysis | |
| Retrospective Studies | |
| Risk Factors |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11426612 | The significance of autoantibodies in non-Hodgkin's lymphoma. | Leuk Lymphoma | 2000 | https://conductscience.org/library/papers/11426612 | PubMed |
| 2 | 12630755 | High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis. | Lupus | 2003 | https://conductscience.org/library/papers/12630755 | PubMed |
| 3 | 11590582 | Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases. | Semin Arthritis Rheum | 2001 | https://conductscience.org/library/papers/11590582 | PubMed |
| 4 | 12892393 | Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. | Lupus | 2003 | https://conductscience.org/library/papers/12892393 | PubMed |
| 5 | 7640230 | Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7640230 | PubMed |
| 6 | 16547696 | "Primary" antiphospholipid syndrome evolving into Waldenstrom's macroglobulinaemia: a case report. | Clin Rheumatol | 2007 | https://conductscience.org/library/papers/16547696 | PubMed |
| 7 | 12038453 | Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. | Eur J Haematol | 2002 | https://conductscience.org/library/papers/12038453 | PubMed |
| 8 | 11704713 | Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. | Medicine (Baltimore) | 2001 | https://conductscience.org/library/papers/11704713 | PubMed |
| 9 | 15708888 | Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/15708888 | PubMed |
| 10 | 10968896 | Antiphospholipid antibodies, malignancies and paraproteinemias. | J Autoimmun | 2000 | https://conductscience.org/library/papers/10968896 | PubMed |
| 11 | 16721493 | High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma. | Clin Rheumatol | 2007 | https://conductscience.org/library/papers/16721493 | PubMed |
| 12 | 15297851 | Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. | Hematol J | 2004 | https://conductscience.org/library/papers/15297851 | PubMed |
| 13 | 14593307 | The catastrophic antiphospholipid syndrome--Asherson's syndrome. | Ann Med Interne (Paris) | 2003 | https://conductscience.org/library/papers/14593307 | PubMed |
| 14 | 15361392 | Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. | Ann Rheum Dis | 2004 | https://conductscience.org/library/papers/15361392 | PubMed |
| 15 | 10996834 | Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). | Am J Hematol | 2000 | https://conductscience.org/library/papers/10996834 | PubMed |
| 16 | 12759289 | Long term outcome of catastrophic antiphospholipid syndrome survivors. | Ann Rheum Dis | 2003 | https://conductscience.org/library/papers/12759289 | PubMed |
| 17 | 8115979 | Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. | Thromb Haemost | 1993 | https://conductscience.org/library/papers/8115979 | PubMed |
| 18 | 7988947 | A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study. | Haemostasis | 1994 | https://conductscience.org/library/papers/7988947 | PubMed |
| 19 | 16466624 | The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. | Clin Exp Rheumatol | 2006 | https://conductscience.org/library/papers/16466624 | PubMed |
| 20 | 16868979 | Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. | Arthritis Rheum | 2006 | https://conductscience.org/library/papers/16868979 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41299702 | Catastrophic antiphospholipid syndrome following surgery for Libman-Sacks endocarditis: A case report and literature review. | J Cardiothorac Surg | 2025 | https://conductscience.org/library/papers/41299702 | PubMed |
| 36662720 | Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients. | PLoS One | 2023 | https://conductscience.org/library/papers/36662720 | PubMed |
| 35847716 | Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review. | EJHaem | 2020 | https://conductscience.org/library/papers/35847716 | PubMed |
| 31583137 | The Conundrum of Septic Shock Imitators in Patients with Hematologic Cancers: Case Presentation and Possible Differential Diagnoses. | Case Rep Crit Care | 2019 | https://conductscience.org/library/papers/31583137 | PubMed |
| 26927441 | Treatment of catastrophic antiphospholipid syndrome. | Curr Opin Rheumatol | 2016 | https://conductscience.org/library/papers/26927441 | PubMed |
| 22203433 | The future of autoimmunity. | Clin Rev Allergy Immunol | 2012 | https://conductscience.org/library/papers/22203433 | PubMed |
| 20425537 | Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome. | Curr Rheumatol Rep | 2010 | https://conductscience.org/library/papers/20425537 | PubMed |
| 19048416 | Malignancies and catastrophic anti-phospholipid syndrome. | Clin Rev Allergy Immunol | 2009 | https://conductscience.org/library/papers/19048416 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17522949
GET https://conductscience.org/api/papers/v1/17522949/references?page=2